– Ashfaq A, Marghoob JM, Braun RP. Atlas of Dermoscopy. Second edition, Taylor & Francis Group, LLC. 2012.
– Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115–8.
– Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, et al. The Genetic Evolution of Melanoma from Precursor Lesions. N Engl J Med. 2015;373(20):1926–36.
– Sarda SP, Suarez R, Malvehy Guilera J. Glowing in the Dark: Use of Confocal Microscopy in Dark Pigmented Lesions. Dermatol Clin. 2016;34(4):431–42.
1 Wiesner T. Genomic Rearrangements in Unusual and Atypical Melanocytic Neoplasms. JAMA Dermatol. 2016;152(3):260–2.
2 Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, et al. The Genetic Evolution of Melanoma from Precursor Lesions. N Engl J Med. 2015;373(20):1926–36.
3 Grob JJ, Bastuji-Garin S, Vaillant L, Roujeau JC, Bernard P, Sassolas B, et al. Excess of Nevi Related to Immunodeficiency: A Study in HIV–Infected Patients and Renal Transplant Transplant Recipients. Journal of Investigative Dermatology. 1996;107(5):694–7.
4 Hoang MP, Prieto VG, Burchette JL, Shea CR. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol. 2001;28(8):400–6.
5 Ferrara G, Gianotti R, Cavicchini S, Salviato T, Zalaudek I, Argenziano G. Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview. Dermatol Clin. 2013;31(4):589–98, viii.
6 Steffen C, Thomas D. The man behind the eponyms: Richard L Sutton: periadenitis mucosa necrotica recurrens (Sutton’s ulcer) and leukoderma acquisitum centrifugum-Sutton’s (halo) nevus. Am J Dermatopathol. 2003;25(4):349–54.
7 Krengel S, Hauschild A, Schafer T. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol. 2006;155(1):1–8.
8 Lin J, Koga H, Takata M, Saida T. Dermoscopy of pigmented lesions on mucocutaneous junction and mucous membrane. Br J Dermatol. 2009;161(6):1255–61.
9 Zaal LH, Mooi WJ, Klip H, van der Horst CM. Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands. Plast Reconstr Surg. 2005;116(7):1902–9.
10 Burroni M, Sbano P, Cevenini G, Risulo M, Dell’eva G, Barbini P, et al. Dysplastic naevus vs. in situ melanoma: digital dermoscopy analysis. Br J Dermatol. 2005;152(4):679–84.
11 Silva JH, Sá BC, Avila AL, Landman G, Duprat Neto JP. Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article. Clinics (Sao Paulo). 2011;66(3):493–9.
12 Grob JJ, Bonerandi JJ. The ‘ugly duckling’ sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998;134(1):103–4.
13 Braun RP, Kaya G, Masouye I, Krischer J, Saurat JH. Histopathologic correlation in dermoscopy: a micropunch technique. Arch Dermatol. 2003;139(3):349–51.
14 Liu W, Dowling JP, Murray WK, McArthur GA, Thompson JF, Wolfe R, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol. 2006;142(12):1551–8.
15 Moloney FJ, Menzies SW. Key points in the dermoscopic diagnosis of hypomelanotic melanoma and nodular melanoma. J Dermatol. 2011;38(1):10–5.
16 Marghoob AA MJ, Braun RP. Atlas of Dermoscopy. Taylor & Francis Group, LLC. 2012.
17 Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: A meta-analysis of nevi and melanoma. Cancer Prev Res (Phila). 2010;3(2):233–45.
18 Sarda SP, Suarez R, Malvehy Guilera J. Glowing in the Dark: Use of Confocal Microscopy in Dark Pigmented Lesions. Dermatol Clin. 2016;34(4):431–42.
19 Malvehy J, Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy:
a two-step method. Clin Dermatol. 2002;20(3):297–304.